Explore / Clinical trial
Clinical trial

Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression

Massachusetts General HospitalRecruitingStarted Apr 17, 202620 enrolledUnited StatesNCT07563868

Abstract

This study is being conducted at Massachusetts General Hospital (MGH) to explore whether adding psychedelic coaching can enhance the effects of ketamine or esketamine maintenance treatment in individuals with treatment-resistant depression (TRD). The investigators are currently enrolling participants who are receiving ongoing maintenance intravenous (IV) ketamine or intranasal esketamine (Spravato) treatment at the MGH Ketamine Clinic. Participation in the study will involve adding coaching sessions to your existing ketamine maintenance treatment.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Psychedelic CoachingKetamine CoachingTreatment Resistant Depression (TRD)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.